Novo Nordisk’ weight-loss prospect amycretin has actually shown fat burning of 24 percent after 36 weeks in a mixed stage 1b/2a test.
发布者:BY NICOLAI RAASTRUP,转转请注明出处:https://robotalks.cn/novo-nordisk-to-send-weight-loss-drug-directly-into-crucial-phase-3-trials/